Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|July 14, 2006
Thymoma followed by paroxysmal nocturnal hemoglobinuria: a unique clinical association in the context of multiorgan autoimmunity with a potential role for CD8+ T lymphocytesGiovannella Palmieri, Carmine Selleri, Liliana Montella, et al.
CNS Oncology|July 11, 2019
Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter studyRaffaele Addeo, Giuseppe Lamberti, Giorgia Simonetti, et al.
Frontiers in Oncology|July 25, 2022
Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path?Liliana Montella, Nunzio Del Gaudio, Guglielmo Bove, et al.
Cancers|November 11, 2022
Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic ActivityMassimiliano Berretta, Lissandra Dal Lago, Mattia Tinazzi, et al.
Cancers|February 15, 2022
The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?Liliana Montella, Margaret Ottaviano, Rocco Morra, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2007
Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women > or = 65 years of ageRaffaele Addeo, Vincenzo Faiola, Rosario Guarrasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and toleranceRaffaele Addeo, Michele Caraglia, Sergio Bellini, et al.
Cancers|June 2, 2021
Toward a Personalized Therapy in Soft-Tissue Sarcomas: State of the Art and Future DirectionsLiliana Montella, Lucia Altucci, Federica Sarno, et al.
Cells|August 27, 2021
The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular CarcinomaLiliana Montella, Federica Sarno, Annamaria Ambrosino, et al.
Future Oncology (London, England)|October 27, 2016
Adherence and safety of regorafenib for patients with metastatic colorectal cancer: observational real-life studySalvatore Del Prete, Gregorio Cennamo, Luigi Leo, et al.
Pageof 7